BiotechTube
Home/Chugai Pharmabody Research/Dr. Yuki Tanaka
DY

Dr. Yuki Tanaka

Chief Scientific Officer

Chugai Pharmabody Research

Therapeutic Areas

OncologyImmunologyHematologyInfectious Disease

Chugai Pharmabody Research Pipeline

DrugIndicationPhase
CPR‑PNH‑001Paroxysmal Nocturnal HemoglobinuriaApproved
CPR‑DEN‑001Dengue Virus InfectionPreclinical
CPR‑COV‑001COVID‑19Preclinical
CPR‑CYC‑101Solid TumorsPreclinical
CPR‑CYC‑202Inflammatory DiseasesPreclinical

Leadership Team at Chugai Pharmabody Research

FM
Futa Mimoto, Ph.D.
CEO
HS
Hideaki Shimada, Ph.D.
Chairman
View full Chugai Pharmabody Research profile